Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × Phlebotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 5 Polycythemia Vera 4 Lung Neoplasms 4 Myeloproliferative Disorders 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thymic aplasia 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1

Interventions

Sorafenib 62 Bevacizumab 37 Oxaliplatin 25 Fluorouracil 21 Doxorubicin 19 Gemcitabine 18 durvalumab 17 Nivolumab 17 pembrolizumab 16 Radiosurgery 16 Radiofrequency Ablation 16 Cisplatin 16 lenvatinib 15 Leucovorin 14 Capecitabine 14 atezolizumab 12 Hepatectomy 12 Radiotherapy 11 tremelimumab 10 Irinotecan 10 Cyclophosphamide 10 Carboplatin 9 Blood Specimen Collection 9 Liver Transplantation 8 Ipilimumab 8 Drug Therapy 8 Cryosurgery 8 Chemotherapy, Adjuvant 8 fludarabine 7 Melphalan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548910 2021-03-18

PRICE

Ottawa Hospital Research Institute

Phase NA Completed

62 enrolled 13 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡